Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Molecular Medicine Reports|September 24, 2019
Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validationLei Song, Yi Luo, Xinyue Wang, et al.
Frontiers in Cell and Developmental Biology|January 20, 2017
Plasma Membrane Targeting of Endogenous NKCC2 in COS7 Cells Bypasses Functional Golgi Cisternae and Complex N-GlycosylationRicha Singh, Shams Kursan, Mohamed Y Almiahoub, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|April 10, 2024
Population pharmacokinetics of gentamicin in acute lymphoblastic leukemia pediatric patients compared to non-oncology patientsHisham S Abou-Auda, Fatimah Alotaibi, Sary Alsanea, et al.
Toxics|August 25, 2023
Adverse Responses following Exposure to Subtoxic Concentrations of Zinc Oxide and Nickle Oxide Nanoparticles in the Raw 264.7 CellsNasser B Alsaleh, Mohammed A Assiri, Anas M Aljarbou, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|April 18, 2024
Sorafenib and Piperine co-loaded PLGA nanoparticles: Development, characterization, and anti-cancer activity against hepatocellular carcinoma cell lineSulaiman S Alhudaithi, Mohd Abul Kalam, Lama Binobaid, et al.
Antibiotics (Basel, Switzerland)|September 23, 2022
Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical IsolatesAreej M Alotaibi, Nasser B Alsaleh, Alanoud T Aljasham, et al.
Cureus|October 14, 2022
The Relation Between Body Mass Index and Musculoskeletal InjuryAbdulaziz A Alangari, Mohammed M Almutairi, Abdulmalik M Alrrajeh, et al.
Polymers|October 27, 2022
The Optimization and Evaluation of Flibanserin Fast-Dissolving Oral FilmsAdel F Alghaith, Gamal M Mahrous, Gamal A Shazly, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|June 3, 2026
miRNA-driven sensitization of breast cancer cells to Doxorubicin treatment following exposure to low dose of Zinc Oxide nanoparticlesAli A Alshamrani, Sami B Bin Salman, Nasser B Alsaleh, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|September 25, 2024
miRNA-driven sensitization of breast cancer cells to Doxorubicin treatment following exposure to low dose of Zinc Oxide nanoparticlesAli A Alshamrani, Sami B Bin Salman, Nasser B Alsaleh, et al.
Pageof 4